Fingerprint
Dive into the research topics of 'Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: The first US phase 2 experience'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically